Amanta Healthcare IPO Details
The Amanta Healthcare IPO is a book build issue with a total issue size of ₹126 cr, comprising of fresh issue of 10000000 equity shares. Amanta Healthcare IPO opened for subscription on Sep 01, 2025 and closed on Sep 03, 2025. Amanta Healthcare IPO is set price band at ₹120 to ₹126 per share, with a lot size of 119 shares. Minimum investment for Retail investors was ₹14,994.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Sep 04, 2025, and listed on both the NSE and BSE on Sep 09, 2025.
MUFG Intime India Private Limited has been appointed as the registrar. Beeline Capital Advisors Pvt Ltd are the Book Running Lead Manager for the issue.
Before investing in the Amanta Healthcare IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 120 – 126
- Lot Size
- 119
- Issue Size
- ₹126 Cr
- Minimum Investment
- ₹14994 (119 Shares)
- Listing Date
- 09 September 2025
Current GMP
₹9 (+7.14%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Amanta Healthcare Ltd
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of sterile liquid products. The company focuses on parenteral formulations, packaged using Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. It also manufactures a range of medical devices.
Product Portfolio:
Amanta offers a wide range of large volume parenterals (LVPs) and small volume parenterals (SVPs) across six therapeutic segments, including:
- Fluid therapy (IV fluids)
- Diluents
- Ophthalmic solutions
- Respiratory care
- Irrigation solutions
- Medical devices like first-aid solutions and eye lubricants
The company supports various closure systems (nipple head, twist-off, leur-lock, screw types) and container sizes ranging from 2ml to 1000ml.
Business Model:
Amanta operates through three strategic business units:
- National Sales – Selling over 45 generics under its own brands via a network of 320+ distributors and stockists.
- International Sales – Active in Africa, Latin America, the UK, and other regions with product registrations in 19 countries.
- Product Partnering – Manufacturing for other Indian and international pharmaceutical companies, including under loan license agreements.
As of Fiscal 2025, Amanta exported branded products to 21 countries and had 47 products registered across 120 international jurisdictions.
Manufacturing & R&D:
- Location: Hariyala, District Kheda, Gujarat, India
- Facilities: 4 LVP manufacturing lines (ABFS and ISBM), 3 SVP lines (including ABFS and conventional lines)
- Certifications: GMP (India, WHO format), approvals from Cambodia, Sudan, Philippines, Zimbabwe, and DNV certification for medical devices
- Formulation & Development (F&D): In-house lab with modern equipment for developing and improving sterile liquid dosage forms
Therapeutic Categories:
Products cover a range of categories including antibiotics, antifungals, quinolones, diuretics, anti-anaerobics, ophthalmics, and respiratory medications.
Management & Team:
Led by Managing Director Bhavesh Patel, Amanta benefits from a highly experienced and professional management team. As of March 31, 2025, the company employed 123 personnel in its F&D and quality control labs.
Competitive Strengths:
- Well-established manufacturer with a diverse sterile liquid product portfolio
- Strong manufacturing infrastructure with advanced technologies (ABFS, ISBM)
- Wide domestic and international market reach
- Robust product development and regulatory compliance
- Experienced leadership and a skilled, long-serving workforce
Amanta Healthcare IPO Promoters
- Bhavesh Patel
- Vishal Patel
- Jayshreeben Patel
- Jitendra Kumar Patel
- Milcent Appliances Private Limited
Promoters Holding
Holding Pre Issue
85.60%
Holding Post Issue
63.56%
Amanta Healthcare IPO Objective
The company proposes to utilise the Net Proceeds from the Issue towards the following objects:
- Funding capital expenditure requirements for civil construction work and towards the purchase of equipment, plant and machinery for setting up a new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat;
- Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up a new manufacturing line for SVP at Hariyala, Kheda, Gujarat; and
- General corporate purposes.
Address / Contact Info
Amanta Healthcare Limited
8th Floor, Shaligram Corporates,
C.J. Marg, Ambli, Ahmedabad –
380058, Gujarat, India
Phone: 079 67777600
Email: cs@amanta.co.in
Website: https://www.amanta.co.in/
IPO Snapshot
Book Running Lead Managers
- Beeline Capital Advisors Pvt Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Amanta Healthcare IPO is a Book-building IPO with a total issue size of ₹126 crore. The Amanta Healthcare IPO price band is ₹120 to 126 per share. The Amanta Healthcare IPO subscription opens on Mon, Sep 1, 2025, and closes on Wed, Sep 3, 2025. The Amanta Healthcare IPO will be listed on the BSE,NSE. MUFG Intime India Private Limited is the registrar for the Amanta Healthcare IPO.
The Amanta Healthcare IPO opens on Mon, Sep 1, 2025 and closes on Wed, Sep 3, 2025
Amanta Healthcare IPO Price Band is ₹120 to 126 per share.
Amanta Healthcare IPO lot size is 119 shares, Retail investors need a minimum investment of ₹14994 based on the upper price band
The minimum investment for Amanta Healthcare IPO is ₹14994, based on one lot of 119 shares at the upper price band of ₹126 per share.
Investors can apply for the Amanta Healthcare IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Wed, Sep 3, 2025. The application amount remains blocked until the Amanta Healthcare IPO allotment is finalized.
Amanta Healthcare IPO issue size is ₹126 crores.
Amanta Healthcare IPO allotment date is Wed, Jul 1, 2026.
The registrar for Amanta Healthcare IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited website to check Amanta Healthcare IPO allotment status, refund processing, and other IPO-related information.
The Amanta Healthcare IPO GMP (Grey Market Premium) is ₹9 as of Tue, Sep 9, 2025. Based on the upper price band of ₹126 per share, the estimated Amanta Healthcare IPO listing price is ₹135, indicating a potential listing gain of approximately 0% over the issue price.